This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03004/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03004/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB03004/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03004/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03004
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB03004 n13:DB03004
dcterms:title
1-[(1s)-Carboxy-2-(Methylsulfinyl)Ethyl]-(3r)-[(5s)-5-Amino-5-Carboxypentanamido]-(4r)-Sulfanylazetidin-2-One
adms:identifier
n6:46936551 n7:46506055 n8:DB03004 n9:ACS
n3:IUPAC-Name
n4:271B4641-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4647-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4646-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4643-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4644-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4645-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B463F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B463D-363D-11E5-9242-09173F13E4C5 n4:271B4640-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B463E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B464D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B464E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4648-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4649-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B464B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B464A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B464C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4653-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4655-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4656-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4652-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4651-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4654-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4642-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B464F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4650-363D-11E5-9242-09173F13E4C5